NeoGenomics Investor Relations Material
Latest events
Q1 2025
NeoGenomics
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from NeoGenomics Inc
Access all reports
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through Clinical Services and Pharma Services segments. The Clinical Services segment provides testing services to hospitals, pathologists, oncologists, urologists, other clinicians and researchers, pharmaceutical firms, and other clinical laboratories. The company’s laboratories provide genetic and molecular testing services to hospitals, pathologists, oncologists, urologists, other clinicians and researchers, pharmaceutical firms, academic centers, and other clinical laboratories
Key slides for NeoGenomics Inc
43rd Annual J.P. Morgan Healthcare Conference 2025
NeoGenomics Inc
Q1 2025
NeoGenomics Inc
Latest articles
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
)
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
2 May 2025
Ticker symbol
NEO
Country
🇺🇸 United States